Company news
EMV Capital PLC news in 2019
EMV Capital PLC's news releases, calls and decks from 2019, newest first.
Glycotest receives 2nd $3m tranche of $10m finance
November 21, 2019
Appointment to the Board
October 14, 2019
PDS collaborates with Merck in Phase 2 studies
October 3, 2019
PDS prioritise PDS0101 in high risk HPV to Phase 2
October 1, 2019
PDS - positive data for immunotherapy treatment
September 19, 2019
PDS second quarter 2019 financial results
August 1, 2019
PDS Biotechnology Corp liquidity funding program
July 31, 2019
Result of Annual General Meeting
June 18, 2019
Positive new data demonstrates NEATstiks potential
May 31, 2019
Full Year Results for the year ended 31 Dec 2018
May 22, 2019
PDS Biotechnology journal publication
May 16, 2019
Resignation of CEO
April 25, 2019
Sale of Wanda and Vortex
March 22, 2019
PDS merger with Edge Therapeutics update
March 19, 2019
PDS completes merger with Edge Therapeutics
March 18, 2019
Share Price Movement
March 14, 2019
Results of General Meeting
March 4, 2019
Update on upcoming General Meeting
March 1, 2019
Conclusion of Strategic Review
February 15, 2019
Glycotest Receives First $3m Tranche from Fosun
February 14, 2019
Termination of Formal Sales Process
January 15, 2019